GSK has signed a deal to develop and lease a new 15,000 sq. m, eight-storey building in the Rochester Park area of Singapore that is expected to complete construction towards the end of next year.

GSK Singapore has obtained the Singapore Health Sciences Authority's (HSA) approval for a new indication for Jemperli (dostarlimab) for use with chemotherapy in treating advanced or recurrent ...

[5] Dr. Stephanie Cinthu Stephen Ambrose, GSK Singapore Medical Director, said: "Singapore's expanded regulatory approval of Jemperli redefines the treatment landscape for patients with dMMR/MSI-H ...

The International AIDS Vaccine Initiative (IAVI) together with GlaxoSmithKline Biologicals (GSK Biologicals) have announced a public-private partnership to develop an AIDS vaccine using a new ...

A*STAR (Singapore), Institute for Animal Health (UK), the Swedish National Institute for Infectious Disease Control, the Canadian Science Centre for Human and Animal Health and GSK Biologicals ...

Massive buildings, fast-paced development, and economic growth that flourishes as much as its greenery, the bustling metropolis of Singapore overflows with promising businesses, markets and trade.

Weber is currently President & General Manager at GSK Vaccines, CEO of GSK Biologicals SA in Belgium and member of the GSK global Corporate Executive Team. "We have extremely high expectations for ...

Look out for GlaxoSmithKline Biologicals S.A. hotels with free cancellation or excellent ratings Bagging the best hotel to fit your budget near GlaxoSmithKline Biologicals S.A. doesn’t need to be ...

He applied this research in a case study using data from a clinical trial of a new vaccine from GlaxoSmithKline Biologicals in Brussels. The GSK vaccine was developed for paediatric meningococcal ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

The recent introduction of oil-in-water emulsions as adjuvants in several pandemic vaccines, such as the H1N1 vaccine, has challenged regulatory authorities to establish their safety in the ...